Step seven: ongoing support
Specifically, autoantibodies against the Muscarinic and Cholinergic receptors #3 (M3) and autoantibodies against the Muscarinic and Cholinergic receptor #4 M4) are elevated in 20-30% of all patients suffering from ME/CFS
Biochem Pharmacol 2024;230(Pt 3):116623
When referring to a survey, unless otherwise noted, we mean the surveys conducted ( by specialty societies as part of the formal RUC process
For higher-risk patients, the guidance suggests targeted mitigation strategies
For Ki67 and p-ERK stainings, blocking and primary antibody dilution were performed using PB buffer composed of 0.05% milk powder (#T145.2, Carl Roth, Germany), 0.25% fish gelatin (#G7765, Sigma-Aldrich, USA), 0.5% Triton X-100 (#BP151-100, Fisher Bioreagents, Germany), 20 mM HEPES (pH 7.2, #9105.4, Carl Roth, Germany), and 0.9% NaCl (#3957.1, Carl Roth, Germany)